Skip to main content

Table 2 Characteristics of the patients in IS, HC and INF groups

From: Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

Groups

Vaccine

N

Sex (Female/Male)

Age (Mean ± SD)

Age Min–Max

IS

CoronaVac

58

43/15

49.5 ± 12.5

(27–86)

BNT162b2

46

31/15

40.52 ± 11.86

(19–73)

HC

CoronaVac

142

97/45

62.56 ± 16.1

(24–90)

BNT162b2

121

72/49

38.64 ± 13.63

(18–77)

INF

 

74

36/38

45.78 ± 11.71

(21–89)

  1. (IS Immunosuppressive group, HC Healthy controls, INF Infection group)
Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us